Alterations in PTEN gene/protein levels in human gliomas have been demonstrated as one of the most important mechanisms involved in the constitutive activation of PI3K/Akt/mTor signaling pathway leading to tumor progression, decreased overall survival, and therapeutic resistance in patients with glioma [12,14,15,16,17]. This evidence concerns the gene MTOR and neoplasm.